Porphyromonas gingivalis

Porphyromonas gingivalis is the main bacterium behind gum disease (periodontitis), and it turns up far from the mouth: in artery plaque, in damaged heart muscle and in the brains of people with Alzheimer's disease. The biology linking it to heart disease and dementia is plausible and partly worked out. But treatments aimed at the bacterium have not helped cognition, and the heart link has not passed the tests for cause and effect.

Treat gum disease for its own sake and, if you have diabetes, for blood-sugar control — not as a way to prevent heart attacks or treat Alzheimer's. No drug or rinse aimed at this bacterium is worth taking for those reasons.

Where it is found

P. gingivalis lives in the deep pockets that gum disease opens between gums and teeth. Through ulcerated gum tissue, live bacteria, their endotoxin (lipopolysaccharide, LPS) and their tissue-degrading enzymes, called gingipains, can reach the blood. The bacterium has been recovered from atherosclerotic plaques and infarcted heart muscle.[1] It and its gingipains are also detectable in Alzheimer's brain tissue.[2]

The proposed route to heart disease

Together with a group of fellow gum-disease bacteria (Treponema denticola, Tannerella forsythia, Fusobacterium nucleatum), P. gingivalis is thought to feed atherosclerosis in several ways:

  • Fatty plaque. Particles shed by the bacterium carry endotoxin that blocks cholesterol export from immune cells in the artery wall, driving the fat build-up that defines plaque.
  • Unstable plaque. The same endotoxin makes immune cells release enzymes that erode the fibrous cap that keeps a plaque from rupturing.
  • A gut-bacteria metabolite. Blood levels of trimethylamine N-oxide (TMAO), a gut-bacterial product tied to atherosclerosis, track with oral P. gingivalis in heart-attack patients.

These are mechanisms, not outcomes. The link between gum disease and heart disease is consistent in observational studies, but it has not been shown to be cause and effect: a genetic (Mendelian randomisation) study found no causal link between periodontitis and coronary artery disease (odds ratio 1.01, essentially no effect).[3] The American Heart Association calls evidence that gum disease causes heart disease "elusive", and the effect of gum treatment on heart attacks and strokes inconclusive.[4]

The Alzheimer's hypothesis

The brain story goes like this. P. gingivalis and its gingipains cross the blood-brain barrier, partly through the small, routine spills of bacteria into the blood that happen during chewing. In the brain, the endotoxin triggers inflammation in the brain's immune cells and a large release of the inflammatory signal interleukin-1β, while the gingipains break down apolipoprotein E, the carrier that clears amyloid-β, the protein that builds up in Alzheimer's.

People with gum disease do get dementia somewhat more often. Pooling 13 case-control and 11 cohort studies, periodontitis went with about a 15% higher risk over time (hazard ratio 1.15). The pooled odds were about twice as high (odds ratio 2.26), and close to three times for severe gum disease, but less-than-moderate gum disease showed no link. Reverse causation is very plausible: people developing dementia neglect their teeth.[5]

Targeting the bacterium hasn't helped cognition

The decisive test has been run. The GAIN trial gave 643 people with mild-to-moderate Alzheimer's atuzaginstat, a drug that directly blocks gingipains. It failed both of its main goals, for cognition and for daily function. A pre-planned subgroup with P. gingivalis detectable in saliva seemed to decline more slowly, but that only generates a hypothesis. The drug also carried signs of liver toxicity, and those halted its development.[6]

A small 24-week trial in 66 people with mild Alzheimer's found that wiping the mouth with chlorhexidine shifted their gum bacteria but did not significantly improve cognition scores. Its main outcome was the bacteria, not cognition, and it compared against usual care, with no placebo or blinding.[7]

Together these suggest that established brain damage does not reverse on a short timescale, even when the microbial driver is reduced. That fits the wider pattern in dementia prevention: the levers work before damage sets in, not as rescue.

What to do

  1. Look after your gums with twice-daily fluoride brushing and cleaning between the teeth, and see a dentist if your gums bleed. Stopping smoking and controlling blood sugar make treatment work better. See Oral health.
  2. Don't take on daily chlorhexidine to fight this bacterium; it hasn't helped cognition and it strips helpful mouth bacteria. See Mouthwash.
  3. Treat claims that a pill or rinse against P. gingivalis prevents heart disease or Alzheimer's as unproven.

Further reading

  • Sabbagh MN, Decourt B. COR388 (atuzaginstat): an investigational gingipain inhibitor for Alzheimer disease. Expert Opin Investig Drugs 2022.[8]
  • Bell S et al. Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study. Atherosclerosis 2020.[9]
  • Tran AH et al. Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2026. [10]
— § —